Publication at First Faculty of Medicine |
2017
Abstract
Sweet syndrome, alternatively called acute febrile neutrophilic dermatosis, is a quite rare skin disorder, which can be associated with a large group of diseases and use of certain drugs. This work reports a case of a 71-year-old male patient with myelodysplastic syndrome treated with an analogue of granulocyte colony-stimulating factor (G-CSF) and chemotherapeutic drug - azacitidine, in whom Sweet syndrome appeared.
Both, haematological disease itself and drug used for its treatment, could be involved in the pathogenesis of this disease. Authors present diagnostic criteria of Sweet syndrome, list of associated states and overview of current literature.